XML 16 R6.htm IDEA: XBRL DOCUMENT v3.23.2
Consolidated Statement of Equity - USD ($)
$ in Thousands
Total
Total Shareholders’  Equity
Par Value
Additional Paid in Capital
Accumulated Deficit
Accumulated Other Comprehensive Income (Loss)
Total Noncontrolling Interests
Operating Partnership Noncontrolling Interest
Partially Owned Properties Noncontrolling Interest
Balance at beginning of period at Dec. 31, 2021 $ 2,987,033 $ 2,836,308 $ 2,247 $ 3,610,954 $ (776,001) $ (892) $ 150,725 $ 150,241 $ 484
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net proceeds from sale of common shares 5,032 5,032 3 5,029          
Restricted share award grants, net (300) (300) 3 118 (421)        
Purchase of OP Units (184)           (184) (184)  
Dividends/distributions declared (54,619) (51,879)     (51,879)   (2,740) (2,740)  
Contributions 569           569   569
Distributions (55)           (55)   (55)
Change in market value of Redeemable Noncontrolling Interest in partially owned properties 717 717     717        
Change in fair value of interest rate swap agreements 1,379 1,379       1,379      
Adjustment for Noncontrolling Interests ownership in Operating Partnership 0 (217)   (217)     217 217  
Net income 13,866 13,092     13,092   774 692 82
Balance at end of period at Mar. 31, 2022 2,953,438 2,804,132 2,253 3,615,884 (814,492) 487 149,306 148,226 1,080
Balance at beginning of period at Dec. 31, 2021 2,987,033 2,836,308 2,247 3,610,954 (776,001) (892) 150,725 150,241 484
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Change in fair value of interest rate swap agreements 4,462                
Balance at end of period at Jun. 30, 2022 2,941,177 2,793,191 2,263 3,637,459 (850,101) 3,570 147,986 146,888 1,098
Balance at beginning of period at Mar. 31, 2022 2,953,438 2,804,132 2,253 3,615,884 (814,492) 487 149,306 148,226 1,080
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net proceeds from sale of common shares 18,484 18,484 9 18,475          
Restricted share award grants, net 2,678 2,678 1 3,588 (911)        
Dividends/distributions declared (54,828) (52,116)     (52,116)   (2,712) (2,712)  
Distributions (61)           (61)   (61)
Change in market value of Redeemable Noncontrolling Interest in partially owned properties 527 527     527        
Change in fair value of interest rate swap agreements 3,083 3,083       3,083      
Adjustment for Noncontrolling Interests ownership in Operating Partnership 0 (488)   (488)     488 488  
Net income 17,856 16,891     16,891   965 886 79
Balance at end of period at Jun. 30, 2022 2,941,177 2,793,191 2,263 3,637,459 (850,101) 3,570 147,986 146,888 1,098
Balance at beginning of period at Dec. 31, 2022 2,993,851 2,869,720 2,333 3,743,876 (881,672) 5,183 124,131 123,015 1,116
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net proceeds from sale of common shares 65,813 65,813 44 65,769          
Restricted share award grants, net (1,530) (1,530) 5 (1,127) (408)        
Conversion of OP Units 0 2,419 2 2,417     (2,419) (2,419)  
Dividends/distributions declared (57,175) (54,912)     (54,912)   (2,263) (2,263)  
Contributions 7,884           7,884   7,884
Distributions (53)           (53)   (53)
Change in fair value of interest rate swap agreements (1,021) (1,021)       (1,021)      
Adjustment for Noncontrolling Interests ownership in Operating Partnership 0 (431)   (431)     431 431  
Net income 10,689 10,202     10,202   487 423 64
Balance at end of period at Mar. 31, 2023 3,018,458 2,890,260 2,384 3,810,504 (926,790) 4,162 128,198 119,187 9,011
Balance at beginning of period at Dec. 31, 2022 2,993,851 2,869,720 2,333 3,743,876 (881,672) 5,183 124,131 123,015 1,116
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Change in fair value of interest rate swap agreements 4,099                
Balance at end of period at Jun. 30, 2023 2,982,859 2,855,788 2,385 3,813,864 (969,743) 9,282 127,071 117,766 9,305
Balance at beginning of period at Mar. 31, 2023 3,018,458 2,890,260 2,384 3,810,504 (926,790) 4,162 128,198 119,187 9,011
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net proceeds from sale of common shares 294 294   294          
Restricted share award grants, net 2,899 2,899 1 3,459 (561)        
Purchase of OP Units (72)           (72) (72)  
Dividends/distributions declared (57,193) (54,936)     (54,936)   (2,257) (2,257)  
Contributions 287           287   287
Distributions (52)           (52)   (52)
Change in fair value of interest rate swap agreements 5,120 5,120       5,120      
Adjustment for Noncontrolling Interests ownership in Operating Partnership 0 (393)   (393)     393 393  
Net income 13,118 12,544     12,544   574 515 59
Balance at end of period at Jun. 30, 2023 $ 2,982,859 $ 2,855,788 $ 2,385 $ 3,813,864 $ (969,743) $ 9,282 $ 127,071 $ 117,766 $ 9,305